NASDAQ : TMDX

TransMedics Group, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 67.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.33B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

TransMedics Group, Inc. (TMDX) reported revenue of 668.47M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue668.47M605.49M441.54M241.62M93.46M30.26M
Cost of Revenue276.12M242.69M179.46M87.53M28.19M9.10M
Gross Profit392.35M362.81M262.08M154.09M65.27M21.16M
Selling, General & Admin218.27M185.17M168.62M119.55M69.90M38.28M
Research & Development92.47M69.06M55.97M36.05M26.81M22.30M
Operating Expenses310.74M254.22M224.59M155.61M96.71M60.59M
Operating Income81.61M108.58M37.50M-1.51M-31.44M-39.43M
Interest Expense-21.24M-13.78M-14.41M-10.79M-3.73M-3.87M
Interest & Investment Income12.30M11.40M13.40M
Currency Exchange Gain (Loss)-2.70M-1.00M700.00K-1.00M
Other Non Operating Income (Expenses)2.59M2.32M-1.41M12.85M-427.00K123.00K
EBT Excluding Unusual Items72.55M107.52M35.78M541.00K-35.59M-44.18M
Other Unusual Items-575.00K
Pretax Income72.55M107.52M35.78M-26.67M-36.16M-44.18M
Income Tax Expense-79.14M-82.77M316.00K-1.64M66.00K36.00K
Net Income151.70M190.29M35.46M-25.03M-36.23M-44.22M
Net Income to Common151.70M190.29M35.46M-25.03M-36.23M-44.22M
Shares Outstanding (Basic)34.33M33.99M33.23M32.52M29.56M27.62M
Shares Outstanding (Diluted)38.42M40.54M35.22M32.52M29.56M27.62M
EPS (Basic)4.425.601.07-0.77-1.23-1.60
EPS (Diluted)4.014.871.01-0.77-1.23-1.60
Free Cash Flow79.04M133.59M-80.94M-164.88M-57.72M-32.38M
Free Cash Flow Per Share2.063.29-2.30-5.07-1.95-1.17
Gross Margin58.69%59.92%59.36%63.77%69.84%69.92%
Operating Margin12.21%17.93%8.49%-0.63%-33.64%-130.29%
Profit Margin22.69%31.43%8.03%-10.36%-38.77%-146.11%
Free Cash Flow Margin11.82%22.06%-18.33%-68.24%-61.76%-107.01%
EBITDA115.63M134.47M57.25M6.66M-27.96M-37.61M
EBITDA Margin17.30%22.21%12.97%2.76%-29.92%-124.28%
D&A For EBITDA34.02M25.89M19.76M8.18M3.48M1.82M
EBIT81.61M108.58M37.50M-1.51M-31.44M-39.43M
EBIT Margin12.21%17.93%8.49%-0.63%-33.64%-130.29%
Effective Tax Rate0.88%
Revenue as Reported668.47M605.49M441.54M241.62M93.46M30.26M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents472.68M488.37M336.65M394.81M201.18M25.58M
Short-Term Investments66.87M
Cash & Short-Term Investments472.68M488.37M336.65M394.81M201.18M92.45M
Receivables104.14M84.28M97.72M63.58M27.61M5.93M
Inventory58.44M48.88M46.55M44.23M20.61M14.86M
Prepaid Expenses15.87M16.25M16.29M8.03M2.90M5.46M
Total Current Assets651.12M637.78M497.22M510.65M252.29M118.70M
Property, Plant & Equipment702.42M332.81M292.45M180.49M24.35M15.69M
Goodwill11.55M11.55M11.55M11.99M
Other Intangible Assets1.95M2.15M2.35M
Long-Term Deferred Tax Assets78.68M83.54M
Other Long-Term Assets20.63M739.00K708.00K562.00K500.00K500.00K
Total Assets1.46B1.07B804.08M706.05M277.15M134.89M
Accounts Payable12.91M10.35M10.29M12.72M3.34M6.65M
Accrued Expenses58.60M62.74M45.15M38.22M18.64M16.34M
Current Portion of Long-Term Debt20.00M10.00M
Current Portion of Leases3.65M3.31M2.73M2.04M1.44M
Current Unearned Revenue3.13M2.90M1.74M1.96M241.00K250.00K
Total Current Liabilities98.28M89.31M59.91M54.93M23.66M23.24M
Long-Term Debt494.00M502.39M509.31M506.20M58.70M35.20M
Long-Term Leases350.07M3.58M6.25M7.71M7.42M8.60M
Other Long-Term Liabilities3.99M
Total Liabilities946.34M595.27M575.47M568.85M89.77M67.04M
Common Stock774.22M750.93M697.21M641.11M666.28M510.49M
Retained Earnings-255.95M-277.95M-468.24M-503.70M-478.68M-442.45M
Comprehensive Income & Other-210.00K124.00K-364.00K-199.00K-225.00K-188.00K
Total Common Equity518.05M473.10M228.60M137.20M187.38M67.85M
Shareholders' Equity518.05M473.10M228.60M137.20M187.38M67.85M
Total Liabilities & Equity1.46B1.07B804.08M706.05M277.15M134.89M
Total Debt867.72M519.28M518.29M515.95M67.56M43.80M
Net Cash (Debt)-395.05M-30.91M-181.64M-121.13M133.63M48.65M
Net Cash Per Share-10.28-0.76-5.16-3.734.521.76
Filing Date Shares Outstanding34.68M34.30M33.66M32.72M32.20M27.96M
Total Common Shares Outstanding34.63M34.27M33.62M32.67M32.14M27.79M
Working Capital552.84M548.48M437.30M455.72M228.63M95.47M
Book Value Per Share14.9613.816.804.205.832.44
Tangible Book Value506.50M459.60M214.90M122.86M187.38M67.85M
Tangible Book Value Per Share14.6313.416.393.765.832.44
Land16.26M2.65M
Machinery358.84M351.37M297.08M175.63M19.45M12.99M
Construction In Progress9.76M2.17M6.66M6.25M482.00K5.27M
Leasehold Improvements25.83M25.11M22.95M13.35M12.41M1.32M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income151.70M190.29M35.46M-25.03M-36.23M-44.22M
Depreciation & Amortization34.02M25.89M19.76M8.18M3.48M1.82M
Other Amortization2.40M1.30M
Loss (Gain) From Sale of Assets80.00K17.00K
Asset Writedown & Restructuring Costs27.21M
Loss (Gain) From Sale of Investments488.00K1.36M
Stock-Based Compensation37.09M36.86M33.22M19.79M10.32M6.88M
Other Operating Activities-65.08M-79.95M5.34M1.17M2.89M2.30M
Change in Accounts Receivable618.00K13.95M-34.31M-33.82M-21.68M840.00K
Change in Inventory-23.68M-7.72M-8.35M-28.09M-8.02M-4.89M
Change in Accounts Payable3.12M-19.00K-1.40M6.96M-3.27M5.09M
Change in Unearned Revenue1.56M1.14M-203.00K83.00K7.00K
Change in Other Net Operating Assets4.18M11.02M-738.00K10.52M6.21M1.96M
Operating Cash Flow145.93M192.84M48.80M-13.03M-45.82M-28.86M
Capital Expenditures-66.89M-59.25M-129.74M-151.85M-11.91M-3.52M
Cash Acquisitions441.00K-14.89M
Sale (Purchase) of Intangibles-27.21M
Investment in Securities66.42M32.79M
Investing Cash Flow-66.89M-59.25M-129.30M-193.95M54.51M29.27M
Long-Term Debt Issued460.00M58.51M
Total Debt Issued460.00M58.51M
Long-Term Debt Repaid-52.07M-36.05M
Total Debt Repaid-52.07M-36.05M
Net Debt Issued (Repaid)407.93M22.46M
Issuance of Common Stock11.79M17.00M22.87M7.11M145.47M1.39M
Repurchase of Common Stock-315.00K-138.00K
Other Financing Activities-14.62M
Financing Cash Flow11.47M16.86M22.87M400.42M167.93M1.39M
Foreign Exchange Rate Adjustments-475.00K1.27M-536.00K193.00K-1.02M-797.00K
Net Cash Flow90.04M151.72M-58.16M193.63M175.60M999.00K
Free Cash Flow79.04M133.59M-80.94M-164.88M-57.72M-32.38M
Free Cash Flow Margin11.82%22.06%-18.33%-68.24%-61.76%-107.01%
Free Cash Flow Per Share2.063.29-2.30-5.07-1.95-1.17
Levered Free Cash Flow44.50M94.00M-102.77M-192.83M-45.96M-15.66M
Unlevered Free Cash Flow57.77M102.62M-93.76M-186.09M-43.64M-13.24M
Cash Interest Paid10.70M10.70M11.30M8.09M3.26M3.33M
Change in Working Capital-14.21M18.38M-45.00M-44.35M-26.76M3.00M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization2.29B4.16B2.09B2.58B1.97B532.04M
Enterprise Value2.68B4.21B2.28B2.67B1.83B464.24M
Last Close Price65.99121.6562.3578.9361.7219.16
PE Ratio16.4421.8559.01
Forward PE36.5747.4056.70
PS Ratio3.426.874.7410.6621.0817.58
PB Ratio4.418.799.1518.7810.527.84
P/TBV Ratio4.529.049.7420.9710.527.84
P/FCF Ratio28.9531.12
P/OCF Ratio15.6821.5642.88
PEG Ratio0.730.93
EV/Sales Ratio4.016.955.1711.0319.6215.34
EV/EBITDA Ratio23.2131.3139.83400.09
EV/EBIT Ratio32.8838.7860.82
EV/FCF Ratio33.9531.52
Debt / Equity Ratio1.681.102.273.760.360.65
Debt / EBITDA Ratio6.993.658.1945.04
Debt / FCF Ratio10.983.89
Net Debt / Equity Ratio0.760.070.800.88-0.71-0.72
Net Debt / EBITDA Ratio3.420.233.1718.184.781.29
Net Debt / FCF Ratio5.000.23-2.24-0.732.311.50
Asset Turnover0.570.650.580.490.450.21
Inventory Turnover5.465.093.952.701.590.68
Quick Ratio5.876.417.258.349.674.23
Current Ratio6.627.148.309.3010.665.11
Return on Equity (ROE)36.29%54.24%19.39%-15.42%-28.39%-51.49%
Return on Assets (ROA)4.33%7.25%3.10%-0.19%-9.54%-17.18%
Return on Invested Capital (ROIC)9.02%23.75%11.12%-0.97%-86.19%-245.59%
Return on Capital Employed (ROCE)6.00%11.10%5.00%-0.20%-12.40%-35.30%
Earnings Yield6.08%4.58%1.70%-0.97%-1.84%-8.31%
FCF Yield3.45%3.21%-3.87%-6.40%-2.93%-6.09%
Buyback Yield / Dilution-1.53%-15.12%-8.30%-10.02%-7.02%-11.80%